Science Resources RSS Feeds
|
 |
 |
 |
Prostate Cancer Current Events | Prostate Cancer News
|
| Page
1 of
99 |
1968 Results |
|
|
|
Sort By:
Page Views | Date |
Prostate specific antigen: A review of PSA use in screening for prostate cancer
Screening for prostate cancer using prostate specific antigen (PSA) testing continues to be problematic. Even though it is unproven whether population-wide screening with PSA can reduce death, illness or disability from prostate cancer, testing has become common in North America. view more (2007-06-19)
PROSTATE CANCER SERIES (p 859)
A four-week series about prostate cancer-the third most common cancer in men worldwide, and the leading male cancer in Europe and North America-begins in this week's issue of THE LANCET. The first article, by Henrik Grönberg of Umea University, Sweden, assesses the epidemiology of prostate cancer, and examines the impact of genetic and... view more... (2003-03-05)
Annual prostate cancer screening test appears to save lives
Men who have a yearly blood test to examine their prostate specific antigen levels are nearly three times less likely to die from prostate cancer than those who don't have annual screenings. view more (2005-10-20)
PSA velocity's clinical usefulness remains unclear
Some studies have suggested that the rate of change of prostate-specific antigen (PSA) levels may correspond with prostate cancer survival. But this does not necessarily mean that PSA velocity will be valuable as a prostate cancer screening tool. view more (2007-10-10)
Low-risk prostate cancer patients face overtreatment
Many low-risk prostate cancer patients are being overtreated and might fare better if doctors monitored the cancer until treatment was necessary. view more (2006-08-16)
University of Kent Study Aims To Improve Information And Support Needs For Older Men With Prostate Cancer
The Centre for Health Services Studies (CHSS) at the University of Kent is currently engaged in an exploratory study of the information and support needs for men aged 75+ with prostate cancer. view more (2004-11-03)
Family history of prostate cancer does not affect some treatment outcomes
In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy (also called seed implants), and patients with this type of family history have clinical and pathologic characteristics similar to men with no family history at all, according... view more... (2009-01-05)
MR imaging helps predict recurrence in prostate cancer patients
MR images taken of prostate cancer patients prior to treatment that show that the cancer has spread outside the prostate gland capsule help predict whether the cancer will return. view more (2007-05-07)
Men with wives, significant others more likely to be screened for prostate cancer
Although the link between early screening and prostate cancer survival is well established, men are less likely to go for early screening unless they have a wife or significant other living with them. view more (2008-12-08)
New prostate cancer marker helps identify men whose cancer is likely to spread
Prostate cancer researchers at Sydney's Garvan Institute, supported by the Cancer Institute NSW, have found a new marker for identifying aggressive prostate cancers. view more (2006-10-04)
Popular Magazines Don't Inform Men About Prostate and Colon Cancer Screening
Decisions about screening for prostate and colon cancer require patients to have accurate, balanced information. Unfortunately, men are not getting this information from popular men's magazines. When articles are available, they often do not provide the information necessary for the reader to make an informed decision about screening. view more (2004-09-08)
Statins may exert influence on prostate cancer growth by reducing inflammation
Cholesterol-lowering drugs called statins may reduce inflammation in prostate tumors, possibly hindering cancer growth, according to a study led by investigators in the Duke Prostate Center. view more (2009-04-27)
Early warning: PSA testing can predict advanced prostate cancer
Researchers who showed that a single prostate specific antigen (PSA) test at age 50 or under could predict the presence of prostate cancer up to 25 years later, (regardless of clinical significance) have now found that a single PSA can be used to predict advanced prostate cancer. view more (2008-02-15)
Prostate Cancer Survival Benefit From A Combination Of Androgen Suppression And External Irradiation
Disease-free survival from advanced prostate cancer could be almost doubled if hormone-suppression therapy is used during and after radiotherapy for a duration of 3 years, suggest authors of an international study in this week's issue of THE LANCET. Long-term survival after radiotherapy for people with advanced prostate cancer is poor. Michel... view more... (2002-07-05)
PSA test has higher accuracy for patients taking finasteride
Finasteride is a drug prescribed for men whose prostates have become enlarged. The drug decreases prostate swelling and helps men with urinary problems. view more (2006-08-16)
African-Americans with prostate cancer more likely to have family history of prostate, breast cancer
African-American men with prostate cancer were more likely to report a family history of prostate cancer and breast cancer among siblings than men who did not have prostate cancer, according to researchers at the University of Michigan Comprehensive Cancer Center. view more (2006-12-04)
OHSU Cancer Institute researchers find novel chemo drug helps treat prostate cancer
Men with a certain type of prostate cancer have been shown to respond to a new chemotherapy drug, Sagopilone, plus prednisone in an international trial led by Oregon Health & Science University Cancer Institute researchers. view more (2008-06-02)
Prostate cancer spurs new nerves
Prostate cancer - and perhaps other cancers - promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from Baylor College of Medicine in the first report of the phenomenon that appears today in the journal Clinical Cancer Research. view more (2008-12-01)
Jefferson scientists find protein potential drug target for treatment-resistant prostate cancer
Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy. view more (2008-01-02)
Prostate cancer patients disease free after 5 years likely to be disease free after 10 years
Prostate cancer patients who receive brachytherapy and remain free of disease for five years or greater are unlikely to have a recurrence at 10 years. view more (2009-07-06)
|
|
| Page
1 of
99 |
1968 Results |
|
|
|
Sort By:
Page Views | Date |
|
|
